BEGIN:VCALENDAR
VERSION:2.0
PRODID:icalendar-ruby
CALSCALE:GREGORIAN
BEGIN:VEVENT
DTSTAMP:20240328T220647Z
UID:09fb3b1b-0b4d-4858-9910-4866963c1046
DTSTART:20230926T083000
DTEND:20230928T180000
CLASS:PRIVATE
DESCRIPTION:
\n
\nWith the approval of the second-ever KRAS G12C inhibito
r\, the field can once again celebrate irrevocable proof that RAS is drugg
able! However\, with so many KRAS G12C drugs in clinic\, the field is now
turning its eyes to the next generation of RAS therapies\, specifically th
ose that can target more mutations\, more RAS isoforms\, and more indicati
ons.
\n
\nAnd so\, the 5th RAS Targeted Drug Development Summit
arrives as the only industry-dedicated\, end-to-end forum to accelerate yo
ur best-in-class RAS therapies from conception through to commercializatio
n.
\n
\nAs the only industry-dedicated\, end-to-end meeting focu
sed on the next-generation of drugs targeting RAS cancers\, the 5th RAS Ta
rgeted Drug Development Summit will bring together 150+ key opinion leader
s to accelerate RAS-targeted drug discovery\, advance pre-clinical drugs t
o clinic\, and optimize translational and clinical development.
\n
\nIndustry leaders such as Mirati Therapeutics\, Revolution Medicines\,
Amgen\, Novartis\, Roche and Loxo Oncology@Lilly will deliver technical\,
data-led clinical updates and workshops on the translational and clinical
development track. On the other hand\, expect to hear about promising can
didates from the likes of BridgeBio\, Biotheryx\, Pfizer\, and Genentech o
n the early discovery and pre-clinical track.
\n
\nUse this excl
usive opportunity to network with the key stakeholders and decision makers
of the RAS industry including CXOs\, VPs\, Senior Directors and Global Le
ads of Oncology\, Translational and Clinical Sciences\, Chemistry and Biol
ogy as well as key academics and oncologists such as Frank McCormick\, Cha
nning Der\, Chiara Ambrogio\, Andrew Aguirre\, Mark Awad and Poulikos Poul
ikakos.
\n
\nURLs:
\nTickets: \;https://go.evvnt.com/1729218-2
?pid=1052
\nBrochure: \;https://go.evvnt.com/1729218-3?pid=1052
\n
\nPrices:
\nConference + Workshop Day (Track A or Track
B) - Drug Developer Pricing: USD 4946.00\,
\nConference Only - Drug D
eveloper Pricing: USD 2999.00\,
\nConference + Workshop Day (Track A
or B) - Solution and Service Provider Pricing: USD 6046.00\,
\nConfer
ence Only - Solution and Service Provider Pricing: USD 3799.00\,
\nCo
nference + Workshop Day (Track A or B) - Academic Pricing: USD 4246.00\,\nConference Only - Academic Pricing: USD 2599.00
\n
\n 
\;
SUMMARY:5th Annual RAS-Targeted Drug Development Summit
BEGIN:VALARM
ACTION:DISPLAY
TRIGGER:-PT1H
SUMMARY:5th Annual RAS-Targeted Drug Development Summit
END:VALARM
END:VEVENT
END:VCALENDAR